It has also been found that the high expression of PLA2G4A in FLT3-mutated AML is not only an indicator of poor prognosis but also related to drug resistance to tyrosine kinase inhibitors and changes in the tumor microenvironment of AML (35). The gene discussed is FLT3; the disease is acute myeloid leukemia.